Heterogeneous treatment effects of GLP‐1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real‐world target trial emulation is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant: R01DK133465
The Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Predoctoral Fellowship
Grant: 2023PDVH1064032
National Institutes of Health (NIH)/National Institute on Aging (NIA)
Grant: R01AG076234
National Institutes of Health (NIH)/National Institute on Aging (NIA)
Grant: R01AG089445
National Institutes of Health
Grant: 5R01AG076234-03
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
National Institutes of Health
Grant: 5R01DK133465-02
Building Equity Improvement into Quality Improvement in the use of New Glucose-lowering Drugs (GLDs) through Individualized Drug Value Assessment in People with Diabetes
National Institutes of Health
Grant: 5R01AG089445-02
iSMART: intelligent Social risk Management in AD/ADRD paTients
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals